African Trypanosomiasis Market Analysed Till 2025 in a New Report : Key Players - Sanofi, Genzyme Corporation, aRigen Pharmaceuticals
QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.
Los Angeles, CA -- (SBWire) -- 04/22/2019 --This report focuses on the global African Trypanosomiasis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the African Trypanosomiasis development in United States, Europe and China.
African Trypanosomiasis, also known as sleeping sickness disease, is one of the rarest infectious diseases that can affect one's sleep pattern to a great extent. It is a parasitic disease caused by protozoan parasite of genus Trypanosoma and is carried by tsetse fly. There are two types of African Trypanosomiasis depending on the parasite: East African Trypanosomiasis caused by Trypanosoma brucei rhodesiense and West African Trypanosomiasis caused by Trypanosomiasis brucei gambiense.
According to WHO, 25,000 new cases of both East and West African Trypanosomiasis are reported each year globally. African Trypanosomiasis is primarily found in subtropical and equatorial Africa. The major driving factors for the growth of the African Trypanosomiasis market in this region are constantly growing number of poor population in East African, prevalence of unhygienic environment, rapid pace of technological advancement in the field of African Trypanosomiasis therapeutics, increasing number of population to opt for healthy lifestyle and the overall growing diagnostic and therapeutic market. On the other hand, the huge cost of drugs involved in the treatment of African Trypanosomiasis and difficulty in availability of these medications would most likely impede the growth of this market.
The symptoms associated with African Trypanosoniasis vary from one stage to another. There are two stages which are as follows. First Stage (Hemolymphatic stage): The first stage is known as hemolymphatic stage due to the blood and lymphatic systems associated with this stage. During this stage, the skin infected by the tsetse fly form a trypanosomal chancre and the lymph nodes of the immune system become infected and enlarged. The various symptoms of the hemolymphatic stage are intermittent fever, headaches, skin lesions, facial edema, tachycardia and weight loss. Second stage (Neurologic or encephalitic stage): During the second stage, the brain becomes affected with few troubles in concentrating. The various symptoms of the neurologic stage are muscle weakness, behavioral changes such as irritability and mood swings, paralysis of a limb, speech disorders and sensory disorders.
Get PDF of this report template: https://www.qyresearch.com/sample-form/form/688739/global-african-trypanosomiasis-market
The key players covered in this study
Sanofi
Genzyme Corporation
aRigen Pharmaceuticals
Immtech Pharmaceuticals
Anacor Pharmaceuticals
...
Market segment by Type, the product can be split into
Trypanosoma Brucei Rhodesiense
Trypanosomiasis Brucei Gambiense
Market segment by Application, split into
Blood Samples
Bone Marrow
Lymph Node Fluid
Cerebrospinal Fluid or Lymph Node Aspirate
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global African Trypanosomiasis status, future forecast, growth opportunity, key market and key players.
To present the African Trypanosomiasis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of African Trypanosomiasis are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
Get Full Report Now at USD 3,900: https://www.qyresearch.com/settlement/pre/4990e1b061e777d663c15d09c126e9fb,0,1,Global%20African%20Trypanosomiasis%20Market%20Size,%20Status%20and%20Forecast%202018-2025
Benefits of Purchasing QY Research Report
- Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
- Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
- Inimitable Expertise: Analysts will provide deep insights about the reports
- Assured Quality: We focus on the quality and accuracy of the report
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Media Relations Contact
Rahul Singh
Director - Digital Marketing
QY Research, Inc.
1-626-295-2442
https://www.qyresearch.com/index/detail/688739/global-african-trypanosomiasis-market
View this press release online at: http://rwire.com/1201591